Clinical trial · Observational
Scripps Tumorgraft Study
NCT01726699CI-TRIAL-00017380completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Study the genetic traits of cancerous tissues and to help improve cancer treatment by developing tumor models for studying new cancer drugs.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Solid Tumor Malignancy or Hematologic Malignancy | Hematopoietic and Lymphoid Cell Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cancer Diagnosis
Primary outcomes (1)
- measure
- Facilitate the development of individualized tumorgraft models for many different types of cancer.
- timeFrame
- 3 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Age 21 or over * diagnosis of a solid tumor malignancy, either resectable or metastatic or a hematologic malignancy * cognitively and emotionally able to give informed consent Exclusion Criteria: * Under age 21 * Not cognitively or emotionally able to give informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.